IL-3 is a novel target to interfere with tumor vasculature
Por um escritor misterioso
Descrição
Frontiers Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor
Tumor-induced neurogenesis and immune evasion as targets of innovative anti- cancer therapies
The role of microenvironment in tumor angiogenesis, Journal of Experimental & Clinical Cancer Research
Crosstalk between angiogenesis and immune regulation in the tumor microenvironment
Targeting the tumor stroma for cancer therapy, Molecular Cancer
Emerging new therapeutic antibody derivatives for cancer treatment
New Technologies Bloom Together for Bettering Cancer Drug Conjugates
Frontiers IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment
Frontiers Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer
Frontiers Molecules promoting circulating clusters of cancer cells suggest novel therapeutic targets for treatment of metastatic cancers
IL-3 is a novel target to interfere with tumor vasculature
New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer: Molecular Therapy - Oncolytics
Tissue architecture in tumor initiation and progression: Trends in Cancer
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
de
por adulto (o preço varia de acordo com o tamanho do grupo)
